| Analysis of biogenic volatile organic compounds in human health and disease J Dummer, M Storer, M Swanney, M McEwan, A Scott-Thomas, ... TrAC Trends in Analytical Chemistry 30 (7), 960-967, 2011 | 130 | 2011 |
| Predicting corticosteroid response in chronic obstructive pulmonary disease using exhaled nitric oxide JF Dummer, MJ Epton, JO Cowan, JM Cook, R Condliffe, CE Landhuis, ... American journal of respiratory and critical care medicine 180 (9), 846-852, 2009 | 102 | 2009 |
| Measurement of breath acetone concentrations by selected ion flow tube mass spectrometry in type 2 diabetes M Storer, J Dummer, H Lunt, J Scotter, F McCartin, J Cook, M Swanney, ... Journal of Breath Research 5 (4), 046011, 2011 | 94 | 2011 |
| Protection by dexamethasone of the functional desensitization to β2‐adrenoceptor‐mediated responses in human lung mast cells LK Chong, DEJ Drury, JF Dummer, P Ghahramani, RP Schleimer, ... British journal of pharmacology 121 (4), 717-722, 1997 | 53 | 1997 |
| Accurate, reproducible measurement of acetone concentration in breath using selected ion flow tube-mass spectrometry JF Dummer, MK Storer, WP Hu, MP Swanney, GJ Milne, CM Frampton, ... Journal of breath research 4 (4), 046001, 2010 | 46 | 2010 |
| Quantification of hydrogen cyanide (HCN) in breath using selected ion flow tube mass spectrometry—HCN is not a biomarker of Pseudomonas in chronic suppurative lung disease J Dummer, M Storer, S Sturney, A Scott-Thomas, S Chambers, ... Journal of breath research 7 (1), 017105, 2013 | 31 | 2013 |
| Detection of monobromamine, monochloramine and dichloramine using selected ion flow tube mass spectrometry and their relevance as breath markers ST Senthilmohan, AJ Kettle, MJ McEwan, J Dummer, SJ Edwards, ... Rapid Communications in Mass Spectrometry: An International Journal Devoted …, 2008 | 31 | 2008 |
| A study on polymorphic forms of rifampicin for inhaled high dose delivery in tuberculosis treatment P Khadka, PC Hill, B Zhang, R Katare, J Dummer, SC Das International Journal of Pharmaceutics 587, 119602, 2020 | 28 | 2020 |
| Considerations in preparing for clinical studies of inhaled rifampicin to enhance tuberculosis treatment P Khadka, J Dummer, PC Hill, SC Das International journal of pharmaceutics 548 (1), 244-254, 2018 | 24 | 2018 |
| Patterns of use of long‐acting bronchodilators in patients with COPD: a nationwide follow‐up study of new users in New Zealand L Parkin, D Barson, J Zeng, S Horsburgh, K Sharples, J Dummer Respirology 23 (6), 583-592, 2018 | 18 | 2018 |
| Pharmacokinetics of rifampicin after repeated intra-tracheal administration of amorphous and crystalline powder formulations to Sprague Dawley rats P Khadka, S Sinha, IG Tucker, J Dummer, PC Hill, R Katare, SC Das European Journal of Pharmaceutics and Biopharmaceutics 162, 1-11, 2021 | 17 | 2021 |
| Diagnosis and treatment of lung disease associated with alpha one‐antitrypsin deficiency: a position statement from the Thoracic Society of Australia and New Zealand J Dummer, CC Dobler, M Holmes, D Chambers, IA Yang, L Parkin, ... Respirology 25 (3), 321-335, 2020 | 15 | 2020 |
| Improving access to health care for people with severe chronic obstructive pulmonary disease (COPD) in Southern New Zealand: qualitative study of the views of health … T Stokes, E Tumilty, ATF Latu, F Doolan-Noble, J Baxter, K McAuley, ... BMJ open 9 (11), e033524, 2019 | 15 | 2019 |
| Effect of Inhaled β2-Agonist on Exhaled Nitric Oxide in Chronic Obstructive Pulmonary Disease M Amer, J Cowan, A Gray, B Brockway, J Dummer PloS one 11 (6), e0157019, 2016 | 15 | 2016 |
| ‘A balancing act’. Living with severe chronic obstructive pulmonary disease in Southern New Zealand: a qualitative study E Tumilty, F Doolan-Noble, ATF Latu, K McAuley, J Dummer, J Baxter, ... Journal of primary health care 12 (2), 166-172, 2020 | 14 | 2020 |
| Underuse of beta‐blockers by patients with COPD and co‐morbid acute coronary syndrome: A nationwide follow‐up study in New Zealand L Parkin, J Quon, K Sharples, D Barson, J Dummer Respirology 25 (2), 173-182, 2020 | 14 | 2020 |
| Anticoagulation strategies in non–critically ill patients with Covid-19 ZK McQuilten, B Venkatesh, V Jha, J Roberts, SC Morpeth, JA Totterdell, ... NEJM evidence 2 (2), EVIDoa2200293, 2023 | 13 | 2023 |
| Studies on the safety and the tissue distribution of inhaled high-dose amorphous and crystalline rifampicin in a rat model P Khadka, S Sinha, IG Tucker, J Dummer, PC Hill, R Katare, SC Das International Journal of Pharmaceutics 597, 120345, 2021 | 12 | 2021 |
| Health care utilisation and health needs of people with severe COPD in the southern region of New Zealand: a retrospective case note review J Dummer, E Tumilty, D Hannah, K McAuley, J Baxter, F Doolan-Noble, ... COPD: Journal of Chronic Obstructive Pulmonary Disease 17 (2), 136-142, 2020 | 11 | 2020 |
| Validating SIFT-MS analysis of volatiles in breath M Storer, J Dummer, S Sturney, M Epton Current Analytical Chemistry 9 (4), 576-583, 2013 | 11 | 2013 |
